Landscape change with oral proteasome maintenance in multiple myeloma patients

Multiple myeloma highlights and more from ASH 2018

Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia

An integrated view of the role of the B cell antigen receptor in lymphoma cell fitness

Myeloma XI study: Quadruplet regimen for transplant eligible patients

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy

ASH 2018: Expert overview of the latest in CLL, ALL and AML

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

Determining the prognosis of patients with myelodysplastic syndromes using machine learning

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

New therapies for transfusion dependent MDS patients

Improving toxicity and outcomes by taking ibrutinib during and after CAR T-cell therapy for relapsed and/or refractory CLL